Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
26,272
Sort by:
The 2027-2032 World Outlook for Pharmaceutical Pharmerging
US$ 1,195.00
This study covers the world outlook for pharmaceutical pharmerging across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
289 pages
The 2027-2032 World Outlook for Pharmaceutical Robots
US$ 1,195.00
This study covers the world outlook for pharmaceutical robots across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Pharmaceutical Solvents
US$ 1,195.00
This study covers the world outlook for pharmaceutical solvents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Pharmaceuticals
US$ 1,195.00
This study covers the world outlook for pharmaceuticals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
288 pages
The 2027-2032 World Outlook for Pharmacokinetics Services
US$ 1,195.00
This study covers the world outlook for pharmacokinetics services across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I...
January 2026
287 pages
The 2027-2032 World Outlook for Pharmerging
US$ 1,195.00
This study covers the world outlook for pharmerging across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
288 pages
The 2027-2032 World Outlook for Phenylketonuria Treatments
US$ 1,195.00
This study covers the world outlook for phenylketonuria treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P....
January 2026
288 pages
The 2027-2032 World Outlook for Pirfenidone
US$ 1,195.00
This study covers the world outlook for pirfenidone across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
287 pages
The 2027-2032 World Outlook for Plant-Based Vaccines
US$ 1,195.00
This study covers the world outlook for plant-based vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Pneumococcal Vaccines
US$ 1,195.00
This study covers the world outlook for pneumococcal vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Pneumonia Therapeutic Drugs
US$ 1,195.00
This study covers the world outlook for pneumonia therapeutic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Pneumonia Therapeutics
US$ 1,195.00
This study covers the world outlook for pneumonia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Pneumonia Vaccines
US$ 1,195.00
This study covers the world outlook for pneumonia vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
287 pages
The 2027-2032 World Outlook for Polypill Products
US$ 1,195.00
This study covers the world outlook for polypill products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Prescription Analgesics
US$ 1,195.00
This study covers the world outlook for prescription analgesics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E...
January 2026
287 pages
The 2027-2032 World Outlook for Prescription Drugs
US$ 1,195.00
This study covers the world outlook for prescription drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), f...
January 2026
288 pages
The 2027-2032 World Outlook for Rabies Treatments
US$ 1,195.00
This study covers the world outlook for rabies treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo...
January 2026
287 pages
The 2027-2032 World Outlook for Recombinant Vaccines
US$ 1,195.00
This study covers the world outlook for recombinant vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Vaccines Sales
US$ 1,195.00
This study covers the world outlook for vaccines sales across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for t...
January 2026
287 pages
